Reply To: Covid 19 Vaccine

January 8, 2021 at 5:39 pm

And the very next paragraph specfically addresses GBS:

People who have previously had Guillain-Barre syndrome

Persons who have previously had GBS may receive an mRNA COVID-19 vaccine. To date, no cases of Guillain-Barre syndrome (GBS) have been reported following vaccination among participants in the mRNA COVID-19 vaccine clinical trials. With few exceptions, the independent Advisory Committee on Immunization Practices (ACIP) general best practice guidelines for immunization do not include a history of GBS as a precaution to vaccination with other vaccines.,for%20enrollment%20in%20clinical%20trials.